who we are

We offer a wide range of core generics with specialties in respiratory, analgesics and anti-infectives.

Because we know how quickly the market can change, we always source, develop and manufacture our products with the now and tomorrow in mind, ensuring continuity of supplies and improving patient offering.

Our expertise of the pharmaceutical industry has allowed us to become a key service provider with our award-winning ready-to-dispense offering to out-of-hours doctors or our renowned over-labelling division. We also provide manufacturing, sourcing and delivery services.

Thanks to 30 years of delivering sustained quality in products and services, Fandex Pharmaceutical has become a key partner for many and a strong player within the generics industry, ensuring continuous growth and setting the path for a successful global expansion.

In 2013, Fandex Pharmaceutical became part of a multi-billion pound corporation through the DCC Vital acquisition, leader in the sales and distribution of pharmaceuticals and medical devices in Britain and Ireland